查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
皮肤科治疗市场份额、规模、趋势、行业分析报告：按治疗领域、按药物类别、按给药途径（局部、口服、肠胃外）、按分销渠道、按地区、细分市场预测，2023-2032年
市场调查报告书
商品编码
1287729

皮肤科治疗市场份额、规模、趋势、行业分析报告：按治疗领域、按药物类别、按给药途径（局部、口服、肠胃外）、按分销渠道、按地区、细分市场预测，2023-2032年

Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Drug Class; By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球皮肤科市场预计将达到 504.7 亿美元。 该报告深入探讨了当前市场动态，并对未来市场增长进行了分析。

由于全球皮肤病患病率不断上升，负担日益加重，皮肤病治疗市场的需求正在激增。 对疾病进展和病因学的认识不断增强，增加了对有效治疗的需求。 老年人口的增加对市场的增长做出了重大贡献。

由于与衰老相关的各种生理变化，老年人更容易患皮肤相关疾病。 例如，结缔组织的变化、皮肤强度和弹性的丧失、皮脂腺分泌减少是老年人的常见现象，导致皮肤科药物的需求增加。

皮肤科是一门多元化的专业，涵盖皮肤、粘膜、头髮和指甲的紊乱和疾病。 此类疾病包括痤疮、多炎性皮炎、皮肤癌、自身免疫性疾病、职业性皮炎和接触性皮炎。 痤疮、酒渣鼻、牛皮癣、特应性皮炎等是非常细分的治疗领域。

由于其功效和针对性方法，生物製剂已成为皮肤病的流行治疗选择，许多药物已获得监管部门的批准，还有更多药物正在开发中。 由于局部治疗方便、副作用较少且有针对性，患者也更喜欢局部治疗而不是全身药物，从而导致对局部皮肤病药物的需求增加。 新兴市场需求的增长、联合疗法的日益采用以及对个性化医疗的关注也推动了该行业的增长。

例如，2022年3月，强生旗下杨森製药公司发布了药物安全性报告，并启动了一项名为VISIBLE的前瞻性临床试验来评估疗效。

皮肤科药物市场报告亮点

  • 由于全球银屑病患病率不断上升以及製造商推出治疗方法，银屑病细分市场占据了最大的市场份额。
  • 皮质类固醇广泛用于治疗各种皮肤病表现，包括牛皮癣、皮炎和痤疮。
  • 父母用药占据了最大的市场份额，因为有多种可用于治疗皮肤病的生物製剂，而生物製剂通常通过肠胃外给药途径服用。因为它会完成。
  • 医院药房行业在市场中占据主导地位，预计在预测期内将继续保持这种主导地位。 如今，人们对皮肤病的认识更加深刻，这导致更多的患者去医院就诊，处方药的销量也随之增加。
  • 北美占据最大的市场份额，预计在预测期内将保持其主导地位。 对皮肤病的认识提高、治疗方法的成熟以及进入该市场的主要参与者正在推动该地区的增长。
  • 主要全球市场参与者：Lupin、诺华公司、罗氏有限公司、辉瑞公司、赛诺菲公司、安进公司、礼来公司、阿斯利康公司、艾伯维公司、强生私人有限公司、LEO Pharma A/S、默克公司、Bausch Health Companies Inc.、百时美施贵宝公司

内容

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章全球皮肤科市场洞察

  • 皮肤科治疗 - 行业概况
  • 皮肤科药物市场动态
    • 驱动因素和机遇
      • 老年人口不断增加
      • 临床研究的增加
    • 制约因素和问题
      • 成本高
  • 杵分析
  • 皮肤科药品行业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球皮肤科药物市场（按治疗领域）

  • 主要发现
  • 简介
  • 痤疮
  • 特应性皮炎
  • 牛皮癣
  • 酒渣鼻样皮炎
  • 其他

第 6 章全球皮肤科药物市场（按药物类别）

  • 主要发现
  • 简介
  • 抗感染药
  • 皮质类固醇
  • 抗痘
  • 钙调神经磷酸□抑製剂
  • 类维生素A
  • 其他

第 7 章全球皮肤科市场（按给药途径）

  • 主要发现
  • 简介
  • 本地
  • 口头
  • 注射用

第 8 章全球皮肤科药物市场（按分销渠道）

  • 主要发现
  • 简介
  • 医院药房
  • 零售药店
  • 网上药店

第 9 章：全球皮肤科药物市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年按地区划分的皮肤科药物市场评估
  • 皮肤科药物市场 - 北美
    • 北美：皮肤科治疗市场，按治疗领域，2019-2032 年
    • 北美：皮肤科治疗市场，按分销渠道划分，2019-2032 年
    • 北美：皮肤科治疗市场，按药物类别，2019-2032 年
    • 北美：皮肤科治疗市场，按给药途径划分，2019-2032 年
    • 皮肤科药物市场 - 美国
    • 皮肤科治疗市场 - 加拿大
  • 皮肤科药物市场 - 欧洲
    • 欧洲：2019-2032 年皮肤科药物市场（按治疗领域）
    • 欧洲：按分销渠道划分的皮肤科市场，2019-2032 年
    • 欧洲：皮肤科药物市场，按药物类别，2019-2032 年
    • 欧洲：按给药途径划分的皮肤科市场，2019-2032 年
    • 皮肤科治疗市场 - 英国
    • 皮肤科药物市场 - 法国
    • 皮肤科药物市场 - 德国
    • 皮肤科药物市场 - 意大利
    • 皮肤科药物市场 - 西班牙
    • 皮肤科药物市场 - 荷兰
    • 皮肤科药物市场 - 俄罗斯
  • 皮肤科药物市场 - 亚太地区
    • 亚太地区：2019-2032 年皮肤科治疗市场（按治疗领域）
    • 亚太地区：皮肤科治疗市场，按分销渠道划分，2019-2032 年
    • 亚太地区：皮肤科治疗药物市场，按药物类别，2019-2032 年
    • 亚太地区：皮肤科治疗市场，按给药途径划分，2019-2032 年
    • 皮肤科药物市场 - 中国
    • 皮肤科药物市场 - 印度
    • 皮肤科药物市场 - 日本
    • 皮肤科药物市场 - 马来西亚
    • 皮肤科药物市场 - 印度尼西亚
    • 皮肤科药物市场 - 韩国
  • 皮肤科药物市场 - 中东和非洲
    • 中东和非洲：2019-2032 年按治疗领域划分的皮肤科药物市场
    • 中东和非洲：2019-2032 年按分销渠道划分的皮肤科药物市场
    • 中东和非洲：皮肤科治疗药物市场（按药物类别），2019-2032 年
    • 中东和非洲：2019-2032 年按给药途径划分的皮肤科药物市场
    • 皮肤科药物市场 - 沙特阿拉伯
    • 皮肤科治疗市场 - 南非
    • 皮肤科药物市场 - 以色列
    • 皮肤科治疗市场 - 阿拉伯联合酋长国
  • 皮肤科药物市场 - 拉丁美洲
    • 拉丁美洲：皮肤科治疗市场，按治疗领域，2019-2032 年
    • 拉丁美洲：皮肤科治疗市场，按分销渠道划分，2019-2032 年
    • 拉丁美洲：皮肤科治疗市场，按药物类别，2019-2032 年
    • 拉丁美洲：按给药途径划分的皮肤科治疗市场，2019-2032 年
    • 皮肤科药物市场 - 墨西哥
    • 皮肤科药物市场 - 巴西
    • 皮肤科药物市场 - 阿根廷

第 10 章竞争格局

  • 扩张和收购分析
    • 扩展名
    • 收购
  • 合作/协作/协议/出版

第 11 章公司简介

  • Lupin
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Sanofi
  • Amgen Inc
  • Lilly
  • AstraZeneca
  • AbbVie Inc.
  • Johnson & Johnson Private Limited
  • LEO Pharma A/S
  • Merck & Co. Inc
  • Bausch Health Companies Inc
  • Bristol-Myers Squibb Company
Product Code: PM1106

The global dermatology drugs market size is expected to reach USD 50.47 billion by 2032, according to a new study by Polaris Market Research. The report "Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Drug Class; By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dermatology drugs market is experiencing a surge in demand due to a growing burden of dermatology diseases globally, with increasing prevalence rates. Increased awareness of disease progression and etiology has increased, leading to a higher demand for effective treatments. The rise in the elderly population has contributed significantly to the market's growth.

Older individuals are more susceptible to skin-related disorders due to various physiological changes associated with aging. For instance, changes in the connective tissue, reduction in skin strength and elasticity, and decrease in sebaceous gland secretions are common in aging individuals, leading to a higher demand for dermatology drugs.

Dermatology is a diverse specialty encompassing disorders and diseases of the skin, mucous membrane, hair, and nails. Conditions in this category include acne, multiple inflammatory dermatoses, skin cancers, autoimmune disease, occupational dermatitis, and contact dermatitis. It's a highly fragmented therapeutic area, under which comes acne, rosacea, psoriasis, atopic dermatitis, and other disorders.

Biologics are becoming a popular treatment option for dermatological conditions due to their effectiveness and targeted approach, with many drugs approved by regulatory bodies and more in development. Patients also increasingly prefer topical treatments over systemic medications due to convenience, fewer side effects, and targeted approach, leading to a rise in the demand for topical dermatology drugs. The rising demand in emerging markets, increasing adoption of combination therapies, and focus on personalized medicine are also driving growth in the industry.

For instance, In March 2022, Johnson & Johnson's Janssen Pharmaceutical Companies initiated a prospective clinical trial named VISIBLE to evaluate the safety and efficacy of a drug for people of color suffering from moderate to severe plaque and/or scalp psoriasis.

Dermatology Drugs Market Report Highlights

  • Psoriasis segment is accounted for the largest market share because of the increasing the prevalence of psoriasis globally and manufacturers launching new medications for the treatment.
  • Corticosteroids segment holds the highest CAGR of the market. in various conditions of skin disorders topical corticosteroids are used widely in conditions such as psoriasis, dermatitis, acne and others.
  • parenteral segment holds the largest share in the market, due to various biologics are available for the dermatological conditions, and biologics are generally taken through the parenteral route of administration.
  • Hospital pharmacy segment dominated the market and willing to continue its dominance over the forecast period. Nowadays peoples are aware with the skin diseases that's why increased in the patient visits to hospitals and sales of prescription drugs increased.
  • North America holds the largest market share in the market and expected to maintain its dominance during the forecast period. Increased in the awareness of skin diseases and raising the treatment and key players making the developments in this market fuels the growth of the region.
  • The global key market players include: Lupin, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi, Amgen Inc., Lilly, AstraZeneca, AbbVie Inc., Johnson & Johnson Private Limited, LEO Pharma A/S, Merck & Co. Inc., Bausch Health Companies Inc., and Bristol-Myers Squibb Company.

Polaris Market Research has segmented the dermatology drugs market report based on therapeutic area, drug class, route of administration, distribution channel, and region:

Dermatology Drugs, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acne
  • Atopic Dermatitis
  • Psoriasis
  • Rosacea
  • Others

Dermatology Drugs, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others

Dermatology Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Topical
  • Oral
  • Parenteral

Dermatology Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Dermatology Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dermatology Drugs Market Insights

  • 4.1. Dermatology Drugs - Industry Snapshot
  • 4.2. Dermatology Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Elderly Population
      • 4.2.1.2. Rise in Clinical Studies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Dermatology Drugs Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dermatology Drugs Market, by Therapeutic Area

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 5.3. Acne
    • 5.3.1. Global Dermatology Drugs Market, by Acne, by Region, 2019-2032 (USD Billion)
  • 5.4. Atopic Dermatitis
    • 5.4.1. Global Dermatology Drugs Market, by Atopic Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.5. Psoriasis
    • 5.5.1. Global Dermatology Drugs Market, by Psoriasis, by Region, 2019-2032 (USD Billion)
  • 5.6. Rosacea
    • 5.6.1. Global Dermatology Drugs Market, by Rosacea, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dermatology Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Dermatology Drugs Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • 6.3. Anti-infectives
    • 6.3.1. Global Dermatology Drugs Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
  • 6.4. Corticosteroids
    • 6.4.1. Global Dermatology Drugs Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.5. Anti-acne
    • 6.5.1. Global Dermatology Drugs Market, by Anti-acne, by Region, 2019-2032 (USD Billion)
  • 6.6. Calcineurin Inhibitors
    • 6.6.1. Global Dermatology Drugs Market, by Calcineurin Inhibitors, by Region, 2019-2032 (USD Billion)
  • 6.7. Retinoids
    • 6.7.1. Global Dermatology Drugs Market, by Retinoids, by Region, 2019-2032 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Dermatology Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Dermatology Drugs Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 7.3. Topical
    • 7.3.1. Global Dermatology Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 7.4. Oral
    • 7.4.1. Global Dermatology Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 7.5. Parenteral
    • 7.5.1. Global Dermatology Drugs Market, by Parenteral, by Region, 2019-2032 (USD Billion)

8. Global Dermatology Drugs Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Hospital Pharmacy
    • 8.3.1. Global Dermatology Drugs Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 8.4. Retail Pharmacy
    • 8.4.1. Global Dermatology Drugs Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 8.5. Online Pharmacy
    • 8.5.1. Global Dermatology Drugs Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)

9. Global Dermatology Drugs Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Dermatology Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Dermatology Drugs Market - North America
    • 9.3.1. North America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.3.2. North America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.3. North America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.3.4. North America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.5. Dermatology Drugs Market - U.S.
      • 9.3.5.1. U.S.: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.6. Dermatology Drugs Market - Canada
      • 9.3.6.1. Canada: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.4. Dermatology Drugs Market - Europe
    • 9.4.1. Europe: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.5. Dermatology Drugs Market - UK
      • 9.4.5.1. UK: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.6. Dermatology Drugs Market - France
      • 9.4.6.1. France: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.7. Dermatology Drugs Market - Germany
      • 9.4.7.1. Germany: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.8. Dermatology Drugs Market - Italy
      • 9.4.8.1. Italy: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.9. Dermatology Drugs Market - Spain
      • 9.4.9.1. Spain: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.10. Dermatology Drugs Market - Netherlands
      • 9.4.10.1. Netherlands: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.11. Dermatology Drugs Market - Russia
      • 9.4.11.1. Russia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.5. Dermatology Drugs Market - Asia Pacific
    • 9.5.1. Asia Pacific: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.5. Dermatology Drugs Market - China
      • 9.5.5.1. China: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.6. Dermatology Drugs Market - India
      • 9.5.6.1. India: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.7. Dermatology Drugs Market - Japan
      • 9.5.7.1. Japan: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.8. Dermatology Drugs Market - Malaysia
      • 9.5.8.1. Malaysia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.9. Dermatology Drugs Market - Indonesia
      • 9.5.9.1. Indonesia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.10. Dermatology Drugs Market - South Korea
      • 9.5.10.1. South Korea: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.6. Dermatology Drugs Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.5. Dermatology Drugs Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.6. Dermatology Drugs Market - South Africa
      • 9.6.6.1. South Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.7. Dermatology Drugs Market - Israel
      • 9.6.7.1. Israel: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.8. Dermatology Drugs Market - UAE
      • 9.6.8.1. UAE: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.7. Dermatology Drugs Market - Latin America
    • 9.7.1. Latin America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.5. Dermatology Drugs Market - Mexico
      • 9.7.5.1. Mexico: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.6. Dermatology Drugs Market - Brazil
      • 9.7.6.1. Brazil: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.7. Dermatology Drugs Market - Argentina
      • 9.7.7.1. Argentina: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Lupin
    • 11.1.1. Company Overview
    • 11.1.2. Financial PerRoute of Administrationance
    • 11.1.3. Distribution Channel Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Novartis AG
    • 11.2.1. Company Overview
    • 11.2.2. Financial PerRoute of Administrationance
    • 11.2.3. Distribution Channel Benchmarking
    • 11.2.4. Recent Development
  • 11.3. F. Hoffmann-La Roche Ltd
    • 11.3.1. Company Overview
    • 11.3.2. Financial PerRoute of Administrationance
    • 11.3.3. Distribution Channel Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Pfizer Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financial PerRoute of Administrationance
    • 11.4.3. Distribution Channel Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Sanofi
    • 11.5.1. Company Overview
    • 11.5.2. Financial PerRoute of Administrationance
    • 11.5.3. Distribution Channel Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Amgen Inc
    • 11.6.1. Company Overview
    • 11.6.2. Financial PerRoute of Administrationance
    • 11.6.3. Distribution Channel Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Lilly
    • 11.7.1. Company Overview
    • 11.7.2. Financial PerRoute of Administrationance
    • 11.7.3. Distribution Channel Benchmarking
    • 11.7.4. Recent Development
  • 11.8. AstraZeneca
    • 11.8.1. Company Overview
    • 11.8.2. Financial PerRoute of Administrationance
    • 11.8.3. Distribution Channel Benchmarking
    • 11.8.4. Recent Development
  • 11.9. AbbVie Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial PerRoute of Administrationance
    • 11.9.3. Distribution Channel Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Johnson & Johnson Private Limited
    • 11.10.1. Company Overview
    • 11.10.2. Financial PerRoute of Administrationance
    • 11.10.3. Distribution Channel Benchmarking
    • 11.10.4. Recent Development
  • 11.11. LEO Pharma A/S
    • 11.11.1. Company Overview
    • 11.11.2. Financial PerRoute of Administrationance
    • 11.11.3. Distribution Channel Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Merck & Co. Inc
    • 11.12.1. Company Overview
    • 11.12.2. Financial PerRoute of Administrationance
    • 11.12.3. Distribution Channel Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Bausch Health Companies Inc
    • 11.13.1. Company Overview
    • 11.13.2. Financial PerRoute of Administrationance
    • 11.13.3. Distribution Channel Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Bristol-Myers Squibb Company
    • 11.14.1. Company Overview
    • 11.14.2. Financial PerRoute of Administrationance
    • 11.14.3. Distribution Channel Benchmarking
    • 11.14.4. Recent Development

List of Tables

  • Table 1 Global Dermatology Drugs Market, by Therapeutic Area, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Dermatology Drugs Market, by Drug Class, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Dermatology Drugs Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Dermatology Drugs Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Dermatology Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 7 North America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 8 North America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 9 North America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 11 U.S.: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 12 U.S.: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Canada: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 15 Canada: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 16 Canada: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 17 Canada: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 18 Europe: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 19 Europe: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 20 Europe: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 21 Europe: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 23 Germany: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 24 Germany: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 France: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 27 France: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 28 France: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 29 France: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 UK: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 31 UK: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 32 UK: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 UK: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Italy: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 35 Italy: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 36 Italy: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Italy: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 42 Spain: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 43 Spain: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 44 Spain: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 45 Spain: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Russia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 47 Russia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 48 Russia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Russia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 54 China: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 55 China: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 56 China: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 57 China: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 Japan: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 59 Japan: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 60 Japan: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Japan: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 India: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 63 India: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 64 India: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 65 India: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 South Korea: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 75 South Korea: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 76 South Korea: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 77 South Korea: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 78 Latin America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 79 Latin America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 80 Latin America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 81 Latin America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 83 Brazil: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 84 Brazil: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Brazil: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Mexico: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 87 Mexico: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 88 Mexico: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 89 Mexico: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Argentina: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 91 Argentina: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 92 Argentina: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 Argentina: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 98 UAE: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 99 UAE: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 100 UAE: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 101 UAE: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 South Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 107 South Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 108 South Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 109 South Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Israel: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 111 Israel: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 112 Israel: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Israel: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Dermatology Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutic Area
  • Figure 7. Global Dermatology Drugs Market, by Therapeutic Area, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Dermatology Drugs Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Drug Class
  • Figure 11. Global Dermatology Drugs Market, by Drug Class, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Route of Administration
  • Figure 13. Global Dermatology Drugs Market, by Route of Administration, 2021 & 2030 (USD Billion)